BAX - Baxter International Inc Stock Analysis
Baxter International Inc (BAX) is a publicly traded company listed on the NYSE. It operates in the Medical Instruments & Supplies industry, part of the broader Healthcare sector. The company has a market capitalization of 11.45B, generates annual revenue of 11.02B, and reports net income of -265.00M. As of the latest data, the stock is trading at 22.27 USD.
From a valuation and risk perspective, the stock presents the following profile: The P/E ratio is unavailable or not meaningful at this time. The PEG ratio is within a normal range, suggesting the stock is fairly priced for its expected growth. The company uses a significant amount of debt to finance its operations, which can boost returns but adds financial risk. The stock offers a moderate dividend yield (3.14%), which may appeal to income-focused investors. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at Sell (2.76), indicating current market sentiment. Institutional ownership is reported at 105.93%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -27.22%, trading within a 52-week range of 17.40 - 37.74.
BAX - Baxter International Inc
22.27
Analyst Consensus
Sell 2.76
BAX – Analyst Rating Summary
- Strong Buy: 0
- Buy: 2
- Hold: 16
- Sell: 6
- Strong Sell: 1
- Total Analysts: 25
| Index: | S&P 500 | P/E: | - | EPS (ttm): | -0.52 | Insider Own: | 0.44% | Shs Outstand: | 513.95M | Perf Week: | 5.90% |
| Market Cap: | 11.45B | Forward P/E: | 9.87 | EPS next Y: | 2.26 | Insider Trans: | 0.00% | Shs Float: | 511.81M | Perf Month: | 10.52% |
| Income(ttm): | -265.00M | PEG: | 1.15 | EPS next Q: | 0.54 | Inst Own: | 105.93% | Short Float: | 6.95% | Perf Quarter: | 25.46% |
| Revenue(ttm): | 11.02B | P/S: | 1.04 | EPS this Y: | 25.36% | Inst Trans: | 1.21% | Short Ratio: | 4.15 | Perf Half Y: | -7.13% |
| Book/sh: | 14.09 | P/B: | 1.58 | EPS next Y: | -4.75% | ROA: | -1.49% | Short Interest: | 35.59M | Perf Year: | -27.22% |
| Cash/sh: | 3.36 | P/C: | 6.63 | EPS next 5Y: | 8.57% | ROE: | -4.70% | 52W Range: | 17.40 - 37.74 | Perf YTD: | 16.54% |
| Dividend Est.: | 0.70 (3.14%) | P/FCF: | 46.92 | EPS past 3/5Y: | - - | ROIC: | -1.64% | 52W High: | 37.74 -40.99% | Beta: | 0.57 |
| Dividend TTM: | 0.52 (2.33%) | Quick Ratio: | 1.18 | Sales past 3/5Y: | -5.95% -1.31% | Gross Margin: | 34.65% | 52W Low: | 17.40 27.99% | Perf 5Y: | -71.40% |
| Dividend Ex-Date: | Nov 28, 2025 | Current Ratio: | 1.84 | EPS Y/Y TTM: | -325.40% | Oper. Margin: | 6.77% | RSI (14): | 72.45 | Volatility: | 3.34% 3.12% |
| Employees: | 38000 | Debt/Eq: | 1.34 | Sales Y/Y TTM: | -21.20% | Profit Margin: | -2.40% | Recom: | 2.83 | Target Price: | 21.33 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 1.24 | EPS Q/Q: | -93.60% | Payout: | - | Rel Volume: | 1.26 | Prev Close: | 21.94 |
| Sales Surprise: | -1.48% | EPS Surprise: | 15.42% | Sales Q/Q: | 5.04% | Earnings: | Feb 12 BMO | Avg Volume: | 8.58M | Price: | 22.27 |
| SMA20: | 9.11% | SMA50: | 12.87% | SMA200: | -7.64% | Overbought: 4.22% | Volume: | 10,784,320 | Change: | 1.50% | |
Graham Classic formula value: -11.97
(P/E=8 * 1g) Min value: -7.74
(current P/E * 2g) Max value: -8.0
Average value: -9.24
About Baxter International Inc
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.